Skip to content
About
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Sign up
Contact
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
View all Diseases
Topics
Diagnostics
Biology
Trial Updates
Treatment
Surgery
Prevention
View all Topics
Conferences
CONy 2020
MDS 2020
AAIC 2020
FENS 2020
EAN 2020
View all Conferences
Features
About
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Sign up
Contact
Prevention
2:45
Using AI to predict epileptic seizures
Daniel Goldenholz
2:16
MS: challenges and the impact of a healthy lifestyle
Abhijit Chaudhuri
3:34
Gene-environment interactions in Huntington’s disease
Anthony Hannan
1:48
Gene-environment interactions and neurodegeneration
Tara Spires-Jones
11:31
Therapeutic landscape for cluster headache
Stewart Tepper
2:09
Challenges in migraine management
Uwe Reuter
20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper
19:11
Benefit of migraine prevention with erenumab
Stewart Tepper
3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter
2:44
PROMISE-1: eptinezumab in episodic migraine
Messoud Ashina
2:52
Fremanezumab in patients with chronic or episodic migraine
Uwe Reuter
2:30
HER-MES study: erenumab versus topiramate in episodic migraine
Uwe Reuter
1:30
Migraine: CGRP mAbs efficacy measured over time
Dagny Holle-Lee
3:29
The evolving migraine prevention landscape: EAN 2020 highlights
Messoud Ashina
2:33
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures
Uwe Reuter
3:16
PEARL study: fremanezumab for chronic or episodic migraine in the real world
Messoud Ashina
1
2
Next
